Arthrex, Inc. designs and manufactures medical devices and surgical products for minimally invasive orthopedic procedures, serving surgeons across sports medicine, trauma, spine, cardiothoracic, and related specialties. Founded in Munich in 1981, the company has grown to 7,000 employees operating in over 80 countries. It develops more than 1,000 new products annually and maintains 160+ surgical training laboratories worldwide.
The company's business model combines product innovation with medical education. Arthrex trains approximately 62,000 healthcare professionals each year through its surgical training programmes, reflecting an integrated approach to both device development and practitioner instruction. Its product portfolio spans arthroscopy, minimally invasive techniques, orthobiologics, and arthroplasty, alongside trauma and spine solutions.
Arthrex remains privately held and family-owned, having evolved from its origins as a small operation into a global medical device manufacturer. The company's stated focus centres on enabling surgeons to perform less invasive procedures that reduce patient recovery time and facilitate faster return to normal activity.
